Article
Therapeutic Potential of Targeting the SUMO Pathway in Cancer
31 Aug 2021
Abstract excerpt
SUMOylation is a dynamic and reversible post-translational modification, characterized more than 20 years ago, that regulates protein function at multiple levels. Key oncoproteins and tumor suppressors are SUMO substrates. In addition to alterations in SUMO pathway activity due to conditions typically present in cancer, such as hypoxia, the SUMO machinery components are deregulated at the genomic level in cancer....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
